We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Medtronic PLC | NYSE:MDT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 80.89 | 0 | 10:34:30 |
From May 2021 to May 2024
By Matt Grossman
Medtronic PLC said Thursday that it estimates organic sales growth will drive a higher adjusted profit in the coming fiscal year.
The Ireland-based medical-technology company forecast organic revenue growth of 9%, compared with full-year revenue of $30.12 billion in fiscal 2021. It forecast adjusted earnings of $5.60 to $5.75 a share.
Analysts surveyed by FactSet were anticipating fiscal 2022 revenue of $32.67 billion and adjusted earnings of $5.75 a share.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
May 27, 2021 07:26 ET (11:26 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Medtronic Chart |
1 Month Medtronic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
